Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P04637 (p53)
 77,613 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The expressions and distributions of PCNA and p53 protein were studied with anti-PCNA and anti-p53 protein MoAbs, using immunohistochemical staining method in salivary gland tumour. The relationship between PCNA and p53 protein was also studied. Results indicated: Malignant mixed tumour (MmT) had a higher proliferating index (PI) of PCNA. The PI could be used as one of adjuvant diagnostic criteria; and as an important parameter for grading mucoepidermoid carcinoma (MEC); The positive expression of p53 might be a good tumour marker for MmT; Tumour tissues with positive expression of p53 had been shown higher PI of PCNA, however there was no significance difference in our group; It remained to be studied later.
 ...
PMID:[The expression of proliferating cell nuclear antigen and p53 protein in salivary gland tumours]. 1068 May 34

Malignant mixed tumor of salivary glands is a rare tumor whose variable behavior and prognosis are related for the most part to the clinical stage and histologic grade of the carcinomatous component. The purpose of this study is to predict prognosis by comparing the histologic grading and subclassification of the carcinomatous component with the immunohistochemical reactivity for E-cadherin, P53 mutation protein, and cellular proliferation (Ki67). Stains were performed on formalin-fixed paraffin-embedded tissue sections from 18 cases of malignant mixed tumor. Clinical follow-up was obtained for each patient. Regional lymph node and distant organ metastases were the criteria for poor prognosis. Of seven cases with lymph nodes metastasis, five were high-grade tumors (with one subsequent death from brain metastasis) and two were low-grade. Of the eight high-grade tumors, positivity for Ki67, p53, and E-cadherin were noted in six, four, and two cases, respectively. In contrast, of the 10 low-grade tumors, two stained with Ki67, five with p53, and none with E-cadherin. Most notably, all seven metastatic cases (as opposed to only one of 11 nonmetastatic tumors) had Ki67 reactivity of more than 10%. We conclude that malignant mixed tumor represents a spectrum of malignancies in which the clinical behavior is closely related to the carcinomatous element. In addition to histologic grading, Ki67 is a useful prognostic marker in the evaluation of malignant mixed tumor while p53 and E-cadherin appear to be of limited value.
 ...
PMID:Prognostic factors in malignant mixed tumors of the salivary gland: correlation of immunohistochemical markers with histologic classification. 1217 Apr 50